Form 8-K Evoke Pharma Inc For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Evoke Pharma (EVOK) Misses Q1 EPS by 4c
May 11, 2016 4:57 PM EDTEvoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.45), $0.04 worse than the analyst estimate of ($0.41).
As of March 31, 2016, the Companys cash and cash equivalents were approximately $6.1 million.
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
... More